They addressed that if the genetic ablation of PLAUR in the kidney is the cause of the effect observed on proteinuria, it is difficult to translate this finding to the pathogenesis of FSGS in humans. The gene discussed is PLAUR; the disease is focal segmental glomerulosclerosis.